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Listeria monocytogenes (LM) has been proposed as vaccine vector in various cancers and
infectious diseases since LM induces a strong immune response. In this study, we developed
a novel and safe LM-based vaccine vector platform, by engineering a triple attenuated mutant
(Lm3Dx) (DactA, DinlA, DinlB) of the wild-type LM strain JF5203 (CC 1, phylogenetic lineage I).
We demonstrated the strong attenuation of Lm3Dxwhilemaintaining its capacity to selectively
infect antigen-presenting cells (APCs) in vitro. Furthermore, as proof of concept, we
introduced the immunodominant Neospora caninum (Nc) surface antigen NcSAG1 into
Lm3Dx. The NcSAG1 protein was expressed by Lm3Dx_SAG1 during cellular infection. To
demonstrate safety of Lm3Dx_SAG1 in vivo, we vaccinated BALB/C mice by intramuscular
injection. Following vaccination, mice did not suffer any adverse effects and only sporadically
shed bacteria at very low levels in the feces (<100 CFU/g). Additionally, bacterial load in
internal organs was very low to absent at day 1.5 and 4 following the 1st vaccination and at 2
and 4 weeks after the second boost, independently of the physiological status of the mice.
Additionally, vaccination of mice prior and during pregnancy did not interfere with pregnancy
outcome. However, Lm3Dx_SAG1 was shed into the milk when inoculated during lactation,
although it did not cause any clinical adverse effects in either dams or pups. Also, we have
indications that the vector persists more days in the injected muscle of lactating mice.
Therefore, impact of physiological status on vector dynamics in the host and mechanisms of
milk shedding requires further investigation. In conclusion, we provide strong evidence that
Lm3Dx is a safe vaccine vector in non-lactating animals. Additionally, we provide first
indications that mice vaccinated with Lm3Dx_SAG1 develop a strong and Th1-biasedgy | www.frontiersin.org August 2021 | Volume 11 | Article 6752191
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Frontiers in Cellular and Infection Microbioloimmune response against the Lm3Dx-expressed neospora antigen. These results encourage
to further investigate the efficiency of Lm3Dx_SAG1 to prevent and treat clinical neosporosis.Keywords: microbial vaccine, Listeria monocytogenes, neosporosis, Neospora caninum, immune response, in vitro
safety, in vivo safetyINTRODUCTION
In both human and veterinary medicine, the implementation of
vaccines revealed to be one of the most effective strategies to prevent
morbidity and mortality from infectious diseases. Case in points
include small-pox (Meyer et al., 2020), rabies (Fischer and Schnell,
2018), polio, mumps, measles, rubella, varicella (Di Pietrantonj et al.,
2020), meningococcal infections, Ebola (Henao-Restrepo et al.,
2017), myxomatosis, canine distemper, parvovirosis, herpesvirus
infections, and leptospirosis (Davis-Wurzler, 2014; Afghah et al.,
2017; Jiang et al., 2019). Currently, many marketed vaccines rely on
live-attenuated or killed/inactivated pathogens. For improved safety
and immunogenicity, significant efforts have been made to develop
alternative approaches using subunit-, DNA-, mRNA- or vector-
based vaccines, even more so in the past months in the light of the
COVID-19 pandemic (Griot et al., 2004; Nielsen et al., 2012;
Fukuhara et al., 2016; Sharma et al., 2020).
Although to this day quantification of induced antibodies is
used to evaluate immunogenicity of vaccines, it is increasingly
recognized that T-cell responses are instrumental for a protective
and sustained immunity against numerous infectious diseases
(Gilbert, 2011; Gray et al., 2018; Jameson and Masopust, 2018;
Peng et al., 2020; Sharma et al., 2020). Indeed, humoral responses
proved insufficient in the control of certain pathogens (Fischer
and Schnell, 2018; Vetter et al., 2018) and there is still an unmet
need for vaccines against diseases such as tuberculosis, HIV
(Gray et al., 2018) or protozoan parasites such as Toxoplasma
gondii and the closely related Neospora caninum (Nc) (Leong
et al., 2009; Wang et al., 2014).
Nc is an obligatory intracellular protozoan parasite belonging
to the phylum apicomplexa and a major infectious cause of
abortion and reproductive failure in cattle and small ruminants
due to transplacental passage of rapidly proliferating tachyzoites
and subsequent infection of the fetus (Schares et al., 1998;
Moreno et al., 2012). Economic losses in the global cattle
industry due to Nc-associated abortion and premature culling
are estimated to amount up to 1.3 billion US $ yearly (Reichel
et al., 2013). Models predict vaccination to be the most cost-
effective approach to reduce abortions and reproductive failure
in cattle herds with high Nc prevalence (Liu et al., 2020).
Additionally, vaccines might prevent severe neuromuscular
disease (Anvari et al., 2020) and fecal oocyst shedding in
infected dogs, which are a major source of exogenous
transmission to cattle (McAllister et al., 1998; Monney et al.,
2011). However, despite strong efforts of the researcher
community, no commercial vaccine is currently available.
Most vaccine trials provided evidence that a Th1-biased or a
balanced Th1/Th2 immune response offer protection against
horizontal and vertical transmission because they simulate thegy | www.frontiersin.org 2immune response during Nc infection that is associated with a
robust development of specific CD4+ and CD8+ T-cells targeting
the intracellular stage of the parasite (Hemphill et al., 2006;
Aguado-Martıńez et al., 2019). In contrast, vaccines triggering
only a humoral immune response proved to be insufficient in
preventing the disease because antibodies act only against the
extracellular stage (Monney et al., 2011; Hemphill et al., 2016).
Over the last decades, Listeria monocytogenes (Lm), a gram-
positive and facultatively intracellular bacterium, has evolved to a
paradigmatic pathogen for immunology research (Cossart and
Lebreton, 2014). Lm infection generates strong innate and
adaptive immune responses and, thus, Lm has been
increasingly recognized as a vaccine vector for the prevention
and therapy of tumors and infectious diseases showing
promising results in clinical trials (Liu, 2006; Singh and
Wallecha, 2011; Wood and Paterson, 2014; Flickinger et al.,
2018; Wendel Naumann and Leath, 2020).
Lm is an opportunistic pathogen that may cause serious
disease including gastroenteritis, septicemia, abortions and
neurolisteriosis in humans and animals (Schlech, 2019; Matle
et al., 2020). Virulence of Lm is essentially governed by a defined
set of crucial virulence factors regulating cellular invasion and
intercellular spread. Invasion of most cells is mediated by the
bacterial surface proteins InlA and InlB that bind cellular
receptors present on a wide range of host cells and induce
bacterial endocytosis (Lecuit et al., 1997). However,
phagocytosis of Lm by professional phagocytes including
antigen-presenting cells (APCs) is independent of theses
receptors. Once internalized, Lm is either processed by the
phagolysosome, or escapes the phagosome prior to
phagolysosomal fusion and enters the cytosol, a process
dependent of proteins encoded by hly, plcA and plcB
(Radoshevich and Cossart, 2018). Once in the cytosol, Lm
relies on an actin-assembly inducing protein encoded by the
actA gene, to highjack the cellular actin machinery enabling Lm
to spread from cell to cell (Radoshevich and Cossart, 2018).
During infection, Lm triggers potent innate and adaptive
immune responses when phagocytosed by APCs (Flickinger
et al., 2018; D’Orazio, 2019). Importantly, proteins from
bacteria that reach the cytosol of infected APCs are processed
and loaded on major histocompatibility complex (MHC) class I
molecules for presentation to CD8+ cytotoxic T-cells
(Ikonomidis et al., 1994; Pamer, 2004; Flickinger et al., 2018;
Chávez Arroyo and Portnoy, 2020; Zeng et al., 2020), while
bacterial proteins that are degraded within phagolysosomes of
APCs are delivered to MHC class II associated epitope
presentation for CD4+ T-cell priming (D’Orazio, 2019).
By deleting one or more crucial virulence genes, Lm virulence
is easily and significantly attenuated preventing systemicAugust 2021 | Volume 11 | Article 675219
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(Brockstedt et al., 2004). Thus, attenuated Lm is a promising
vaccine vector to be used against diseases including neosporosis,
for which a Th1-mediated immune response is required to
confer protection (Ikonomidis et al., 1994; Brockstedt et al.,
2004; Johnson et al., 2011; Wood and Paterson, 2014; Flickinger
et al., 2018; D’Orazio, 2019; Chávez Arroyo and Portnoy, 2020).
Additionally, the Lm vector has the advantage over other
microbial vectors to overcome pre-existent or vector-induced
immunity in the host allowing homologous prime-boost
vaccination schemes without compromising its efficacy in T-
cell priming (Leong et al., 2009).
The aim of our study was to develop an attenuated Lm
vaccine vector (Lm3Dx) platform that is safe and expresses
foreign antigen. To demonstrate proof of concept for triggering
of a Th1 immune response we selected the NcSAG1 as antigen,
which is a highly immunogenic protein, expressed on the surface
of Nc tachyzoites and implicated to have a functional role in host
cell invasion (Hemphill et al., 1997).MATERIAL AND METHODS
Experimental Setup
Additionally to the crucial virulence genes actA, inlA, inlB, the
fosfomycin resistance gene (fosX) was deleted from the parental
JF5203 strain (ST1, CC1) (Aguilar-Bultet et al., 2018). FosX
encodes a protein involved in inherent fosfomycin resistance of
Lm outside the host (Scortti et al., 2018), and deletion renders
the vaccine vector highly sensitive to this antibiotic and selectable
without introducing exogenous antibiotic resistance genes
while cloning. The resulting Lm vector Lm3Dx was first tested
for genetic stability upon serial passaging and for infection
dynamics in canine cell lines as surrogates for epithelial
cells and APCs. The gene coding for the major Nc surface
antigen NcSAG1 (sag1) was fused to the first 300 nucleotides
of actA containing the signal peptide and PEST sequences
to enhance antigen processing (Sewell et al., 2008) and was
inserted into Lm3Dx via homologous recombination to avoid
the introduction of exogenous antibiotic resistance genes.
Homologous recombination, as opposed to plasmid integration
methods used for other Lm-based vaccine vectors, does not
require growth of the engineered vector on selective media
containing antibiotics (Sacco et al., 2016) to ensure retention of
the antigen encoding genes, thereby conferring high safety and
stability to our vaccine strain. Bacterial NcSAG1 expression by
the engineered Lm3Dx-NcSAG1 was confirmed by real-time
PCR (RT-PCR) and Western Blot (WB) before performing in
vivo safety and immunogenicity testing. For the latter, female
pregnant and non-pregnant BALB/c mice were vaccinated
intramuscularly (i.m.) with Lm3Dx expressing NcSAG1 using a
homologous prime-boost vaccination scheme. In mice, bacterial
spread to organs and to newborn pups, fecal and milk shedding
(Table 1), genetic stability of isolated Lm3Dx_NcSAG1 and
indicators of humoral and cellular immune response to NcSAG1
were evaluated.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3Generation and Quality Control of the
Vaccine Vector
Bacterial Strains, Plasmids, and Primers
Bacterial strains and plasmids used in this study are listed in
Supplementary Files S2, S3 and primers in Supplementary File
S4, respectively.
The pMADDactA plasmid used to remove actA was
previously described (Henke et al., 2015). To generate the
pHOSSDinlAB plasmid, flanking regions of the inlAB region
including the first 12 N-terminal nucleotides of inlA and the last
36 C-terminal nucleotides of inlB were amplified with
GoTaq®DNA polymerase (Promega Corporation, Madison,
USA) using the primer pairs DinlA_n_fw_1_SalI/DinlAB_2_rv
(617pb) and DinlAB_3_F/DinlB_R_XmaI, respectively. The two
resulting fragments were then ligated using T4 DNA ligase
(Thermo Fisher Scientific Inc., Waltham, USA) following
digestion of pHOSS1 (Abdelhamed et al., 2015) with XmaI
(New England Labs Inc., Ipswich, MA, USA) and SalI (New
England Labs Inc.) according to the manufacturer’s instruction.
The pMADDfosX plasmid for deletion of fosX was generated by
removing the fosX sequence from a pMADfosX plasmid containing
fosX with its flanking regions. The fosX fragment was generated by
amplification from JF5203 with Hifi cloning (Takarabio Inc.) and
purification with the NucleoSpin® Gel and PCR Clean-up Kit
(Macherey-Nagel, Düren, Germany) after gel electrophoresis. Both
insertion of the resulting fragment into pMADfosX and subsequent
deletion of the fosX sequence from pMADfosX to generate
pMADDfosX were performed with the In-fusion® HD Cloning
Plus (TakaraBio Inc.) technology according to the manufacturer
recommendations. For In-fusion® cloning, the amplification primer
pairs pMADfosX3_F/pMADfosX4_R, pMADfosX1_F/
pMADfosX2_R and pMADDfosX1_F/pMADDfosX2_R were used
to generate pMADfosX and pMADDfosX, respectively. pMADfosX
and pMADDfosX plasmids were Sanger sequenced (3730 DNA
Analyzer, Thermo Fisher Scientific Inc., Waltham, USA) using the
BigDye® Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher
Scientific Inc., Waltham, USA). The primers used for sequencing
(fosX_F, fosX_R, pMAD_F, pMAD_R, fosX_ex_F, fosX_ex_R) are
listed in Supplementary File S4.
For generation of the pMAD_NactA100AA_SAG1_HIS
plasmid, NactA100AA_SAG1_HIS was created in-silico using
the Geneious 8.1 software (Biomatters Inc.) and synthesized and
inserted into pMAD by Twist Bioscience (San Francisco, USA).
Briefly, the sag1 sequence NCLIV_033230 was codon-optimized
for L. monocytogenes using a publicly available web-based
software (http://www.jcat.de/). At the sag1 5’ end, the first 300
nucleotides of actA were added and the 3’ end was fused with a
HIS tag followed by 2 stop codons. In order to ensure insertion of
sag1 into the actA locus, this sequence was inserted between the
two actA flanking regions of the pMADDactA plasmid resulting
in pMAD_NactA100AA_SAG1_HIS. For deletion of the HIS-tag
to generate pMAD_NactA100AA_SAG1 (Map in Suplementary
File S1) the fragment without HIS tag was amplified with the
Hifi cloning system and integrated into pMAD with the In-
fus ion® HD Cloning Plus us ing the pr imer pa i r
SAG1HISdel_F/SAG1HISdel_R (Supplementary File S4).August 2021 | Volume 11 | Article 675219
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In order to prevent permanent insertion of antibiotic resistance
genes into the vector, all mutant strains were generated from
L. monocytogenes strain JF5203 (NCBI Reference Sequence:
NZ_LT985474.1; https://www.ncbi.nlm.nih.gov/nuccore/NZ_
LT985474.1; lineage I, CC 1, ST 1, serotype 4b) by homologous
recombination with either pMAD or pHOSS1 plasmid derivates
(Supplementary File S3). The JF5203DactAmutant generated in
a previous study (Henke et al., 2015) was used as parental mutant
to engineer the vaccine vector. The JF5203DactA/inlA/inlB/fosX
vector (Lm3Dx) was generated by sequential in-frame deletion of
inlA/inlB and fosX genes from the JF5203DactA mutant by
homologous recombination with the respective pMAD
(Arnaud et al., 2004) and pHOSS1 (Abdelhamed et al., 2015)
plasmid derivates described above. Gene deletions were
confirmed by DNA sequencing of the intermediate mutants
and by full genome sequencing of the final vaccine vector
strain (see below).
Finally, Lm3Dx was transformed with the plasmid
pMAD_NactA100AA_SAG1 (Supplementary File S1) to
create Lm3Dx_SAG1 expressing sag1 fused to the 300 first
nucleotides of actA under the control of the actA promotor.
Quality Control
Fosfomycin minimal inhibitory concentrations (MICs) were
determined in Lm WT and Lm3Dx using the fosfomycin E-test
strip (Biomérieux SA, France) after 24h incubation at 37°C as
previously described (Scortti et al., 2006). Genetic stability of
DactAmutant and Lm3Dx was determined in comparison to the
WT by serial passaging under non-selective conditions. Strains
were cultured in 10mL of Bacto Brain Heart Infusion broth (BHI,
Sigma-Aldrich, Buchs, Switzerland) and sub-cultured every 12 h
at a 1/10’000 dilution into fresh BHI broth. Every 10 passages,
10µL of the medium was plated on BHI-Agar plate (Sigma-
Aldrich, Buchs, Switzerland) and cultured 24h at 37°C before
further passaging was done. Every ten passages until passage
number 100, a colony of the plating performed on BHI-Agar was
grown in 10mL of BHI broth and DNA was extracted using the
DNA extraction kit (Invitrogen, PureLink™ Microbiome, DNA
purification Kit). PCR of extracted DNA was performed to
ensure stability of the deletion of each virulence gene (primers
used are listed in Supplementary File S4). Insertion of the sag1
sequence into Lm3Dx was confirmed by colony PCR using the
actA flanking region primer pairs (Supplementary File S4),
resulting in Lm3Dx_SAG1. Furthermore, both Lm3Dx and
Lm3Dx_SAG1 were sequenced by INVIEW Resequencing
(Eurofins Genomics, Constance, Germany) after the first and
100th passage in BHI broth to analyze for single nucleotide point
mutations (SNPs) (https://www.ebi.ac.uk/ena/browser/
view/PRJEB43038).
For confirmation of NcSAG1 expression at the RNA level,
Lm3Dx_SAG1 was cultured in BHI broth overnight at 37°C. The
next day, RNA was extracted with the RNA extraction kit
(RiboPure™ Bacteria, Invitrogen, Thermo Fisher Inc., Waltham,
USA) and contaminating genomic DNA was eliminated with RQ1
RNaseFree DNase (Promega Corporation, Madison, USA). PurifiedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5RNA was then reverse transcribed into cDNA with GoScript™
Reverse Transcriptase (Promega Corporation, Madison, USA)
following the instruction of the manufacturer. PCR for NcSAG1
was performed using NcSAG1_F/NcSAG1_R primers
(Supplementary File S4). NcSAG1 protein expression in
Lm3Dx_SAG1 during infection was confirmed by WB of proteins
extracted from infected canine histiocytic DH82 cells. Briefly, DH82
cells were cultured to confluency in Corning® Cell culture T150
flasks (Fisher scientific Inc., Waltham, USA) and infected at a
multiplicity of infection (MOI) of 40. Six hours post-infection,
infected cells were detached by Trypsin-EDTA (Sigma-Aldrich,
Buchs, Switzerland), centrifuged and the pellet was frozen at
-80°C. After thawing, cells were lysed by sonication (3 cycles of 2
minutes at 40% duty) (Sonifier 450, Branson, Danbury, CT, USA)
and proteins were separated from the cell lysate by centrifugation
(15.000 x g, 15 minutes at 4°C). Fifteen µg each of the unpurified
protein extract, of Nc protein extract as positive control and of the
empty Lm3Dx vector as a negative control, were separated by SDS-
Page and electrophoretically transferred to a nitrocellulose
membrane. The membrane was blocked in PBS/0.1% Tween-20/
2% milk powder for 1 h at RT, and the monoclonal mouse anti-
NcSAG1 antibody (kindly provided by Prof. Dr. Camilla Björkman,
University of Uppsala, Sweden) (Björkman and Hemphill, 1998)
was applied at a dilution of 1:1000 overnight at 4°C. Membranes
were washed four times with PBS supplemented with 0.1% Tween-
20, and were incubated with the goat anti-mouse IgG coupled to
alkaline phosphatase (AP) (Promega, Madison, USA), diluted
1:2000 in PBS-Tween-20. Following four more washes in PBS,
bound antibodies were visualized by developing the AP reaction
using 0.3% NBT/BCIP stock solution (Roche, Basel, Switzerland) in
0.1 M sodium chloride, 5 mMmagnesium chloride, and 0.1 M Tris
(pH 9.5). The enzymatic reaction was stopped by immersing the
membrane in distilled water.
In Vitro Safety
In Vitro Infection Assays
To check whether virulence gene deletion attenuates cellular
infection of the vaccine vector Lm3Dx and whether attenuation is
cell-type specific, canine cell lines representing epithelial cells
(Madin-Darby Canine Kidney, MDCK) and macrophages
(DH82) were infected. The day prior to infection, both cell lines
were seeded in 24-well plates at densities of 0.8 x 105 (MDCK) or 2.5
x 105 cells (DH82) per well, respectively, and were grown in DMEM
medium supplemented with 10% FCS and 50 µg/mL Penicillin/
Streptomycin at 37°C with 5% CO2. One hour prior to infection,
cells were starved in FCS- and antibiotic-free medium. Cells were
then infected with LmWT, Lm DactA, Lm3Dx and Listeria innocua
at a MOI of 1.25. The concentration of the inoculum was
determined by OD600 measurement on a Biospectrometer
® basic
(Vaudaux-Eppendorf AG, Schönenbuch/Basel, Switzerland) and
confirmed by plating of the inoculum on brain heart infusion
(BHI) plates (Sigma-Aldrich). After 1h, cells were washed once
with PBS and DMEM medium supplemented with FCS (2% for
long-term infection assay or 10% for short-term infection assay) and
50 µg/mL gentamicin (Sigma-Aldrich) was added to prevent
extracellular replication.August 2021 | Volume 11 | Article 675219
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infection assays was performed as previously reported (Rupp
et al., 2015). Briefly, infected cells were washed once with PBS
and then harvested in 100 µl of 0.5% Triton X-100 (Sigma–
Aldrich) in distilled water (dH2O) 2, 4, 6, 24, 48 and 72 h post-
infection (pi). Ten-fold serial dilutions of the lysates were plated
on BHI-agar plates, and CFUs per well were calculated. At least
three independent experiments were performed in triplicate.
For long-term infection assays, cells were infected as
described above, but had to be sub-cultured due to cellular
proliferation. At determined timepoints (2, 5, 7, 9 and 12 days
pi) cells were washed once with PBS and then detached using 100
µL of Trypsin-EDTA solution (Sigma-Aldrich). Half of the cell
suspension was transferred in a new 24-well plate with fresh
DMEM medium supplemented with 2% FCS and 50µg/mL
gentamicin for sub-culturing. The other half was incubated
with 2% Triton X-100 (Sigma-Aldrich) in dH2O for 10 min
and then plated in serial dilutions as described above. At the final
timepoint (14 days pi) cells were harvested in 100 µL of 2%
Triton X-100 and further processed as described above. At least
three independent experiments were performed in triplicate.
Immunofluorescence Analysis of In Vitro
Infection Assays
Coverslips with infected cells (DH82 or MDCK) were collected at
2, 6, 24, 48 and 72 hours pi and were fixed in 4%
paraformaldehyde (PFA, Sigma–Aldrich) at 37°C for 15 min.
Immunofluorescence was performed as previously reported
(Rupp et al., 2015). Coverslips were incubated with Listeria O
antiserum (BD Difco, 1:1000 in PBS-T) and phalloidin DyLight
633 (Fisher Scientific, Waltham, MA, USA, 1:500) in PBS-T with
10% normal goat serum (NGS, Agilent Technologies, CA, USA).
After 1 h, coverslips were washed three times with PBS-T,
followed by a 45 min incubation with Alexa Fluor 488 goat
anti-rabbit IgG (Life Technologies, 1:500) and DAPI (1:10,000)
in PBS-T supplemented with 10% NGS. Coverslips were washed
twice with PBS and finally rinsed with dH2O and mounted using
glycergel (Dako). Specimens were imaged using a FV3000
confocal laser scanning microscope (Olympus, Hamburg,
Germany) and were analyzed using FIJI (Schindelin et al., 2012).
In Vivo Safety and Immunogenicity
Mouse Vaccination
All mouse experiments were conducted in compliance with the
Swiss and European Union (Directive no. 2010/63/EU) legislation
for the use of animals for scientific purposes, and animal protocols
were approved by the Bernese Animal Welfare Committee (licenses
BE113/19 and BE103/20). For the experiments, 6-week-old female
and male BALB/c as well as synchronized pregnant mice were
obtained from Charles River Laboratories (Sulzfeld, Germany). All
mice were maintained under conventional day/night cycle in a
temperature-controlled room excepted for the mice used in the milk
excretion experiment, where the cages were kept under a sterile
hood after vaccination, with water and food ad libitum. Two weeks
upon arrival at the facility, mice were randomly distributed into
groups and individually marked. One additional week ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6acclimatization was then given to the mice prior to start of
the experiment.
For each experiment inoculation doses of Lm3Dx_SAG1 or
WT strain were prepared by culturing a colony overnight in 10
mL BHI broth at 37°C. Bacteria were washed 3x with sterile PBS
(Sigma-Aldrich) to remove BHI-broth. Prior to injection, they
were resuspended to an OD600 of 0.8 and sequentially diluted to
the desired concentration in each experiment (1 x 106, 5 x 106
and/or 1 x 107 CFU/50 µL). Concentration was confirmed by
plating of the inoculum on BHI-Agar plates (Sigma-Aldrich) and
CFU counting 24 h after incubation at 37°C. Euthanasia was
performed in a euthanasia chamber using isoflurane and CO2 or
cervical dislocation for pups younger than 3 weeks old.
Experiment 1: Biosafety evaluation of Lm3Dx_SAG1 in non-
pregnant BALB/c female mice.
Mice were randomly allocated into experimental groups of 5 to
6 mice each, with an additional mouse per group used as sentinel.
Three groups were injected i.m. with 50 µL sterile PBS containing
the Lm3Dx_SAG1 vaccine strain at different dosages (1 x 106, 5 x
106, 1 x 107 CFU), one group with the WT strain (1 x 107 CFU)
and the negative control group with 50 µL sterile PBS. Sentinel
mice were used to evaluate Lm transmission between mice in the
same experimental cage. Mice were immunized i.m. in the thigh.
Lm3Dx_SAG1 groups received a primovaccination and two
booster injections, both two weeks apart, and were euthanized 2
weeks following the last immunization (Table 1). Because the
group receivingWT (1 x 107 CFU) had to be euthanized 1.5d after
the first immunization due to severity of clinical signs, 5 additional
mice were inoculated i.m. with 50 µl PBS containing 1x107
Lm3Dx_SAG1 and euthanized 1.5d after inoculation to assess
the attenuation of our Lm3Dx_SAG1 vaccine strain during the
acute phase. At euthanasia, liver, spleen, kidney, uterus, brain,
thigh musculature and GIT of the Lm3Dx_SAG1 vaccinated mice
were retrieved for further evaluation.
Experiment 2: Biosafety evaluation of Lm3Dx_SAG1 in
lactating BALB/c dams and suckling pups.
To assess Lm3Dx_SAG1 excretion in milk and the safety of its
use in lactating dams, we randomly allocated 14 dams with their
respective pups (2-8 days old) into two groups (7 per group).
Based on the results of the first experiment, the Lm3Dx_SAG1
group was injected once with 1 x 107 CFU of Lm3Dx_SAG1 and
the other group with PBS in the thigh musculature. From day 1
to day 4 after inoculation, dams were separated from their pups 1
hour prior to milking once a day (Table 1). Mice were
anesthetized with isoflurane and 1 IU of oxytocin (Sigma) was
injected intraperitoneally. Ten minutes later, milk collection was
started using a custom-made vacuum pump-based milk
collection system. Upon milking, dams were returned to their
pups in a cage under a sterile hood until the following day. Dams
and pups were euthanized at day 4 pi. The liver, spleen, thigh
musculature and GIT of the Lm3Dx_SAG1 vaccinated dams and
their pups were retrieved for further evaluation.
Experiment 3: Assessment of potential effects of
Lm3Dx_SAG1 on pregnancy outcome in BALB/c mice.
The experiment included three experimental groups of 6 mice
each. Two groups were inoculated three times at two-weekAugust 2021 | Volume 11 | Article 675219
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strain at 1x106 and 1x107 CFU respectively, while the control
group was inoculated with 50 µL sterile PBS at each vaccination
(Table 1). The first vaccination was done at day 0 and the first
booster on day 14. On day 22, mice were estrus-synchronized
using the Whitten effect (Whitten, 1957) and were mated from
day 25 to 27 by housing two females and one male in the same
cage. Subsequently, males were removed from the cage and the
third immunization was performed at day 28 (early pregnancy).
Data on fertility (number of female mice that became pregnant),
litter size (number of delivered pups per dam), stillborn mice and
neonatal mortality (number of dead pups from birth until day 2
postpartum (p.p.)); postnatal mortality (number of dead pups
from day 3 p.p. to the end of the experiment) and clinical signs
that occurred during the observation phase were recorded. Dams
and surviving pups were monitored at least 21 days after birth to
rule out possible adverse effects due to treatments. At euthanasia,
liver, spleen, injected thigh musculature and GIT of the
Lm3Dx_SAG1 vaccinated dams and PBS control group were
retrieved for further evaluation.
Microbiological Assessments
Mice in experiments 1 and 3 were monitored for fecal shedding
as follows. In experiment 1, fecal sampling (100 mg/mouse) and
analysis was performed daily from the day prior to the first
vaccine administration until day 7 pi and at day 10 pi. Then, the
same sampling scheme was repeated for the two booster
injections (Table 1). In experiment 3, fecal samples of every
mice were retrieved 1, 2, 4 and 7 days after each vaccine dose
administration and at day 11 and 14 after the third
vaccine administration.
Fecal samples were homogenized in Half-Fraser broth (Fisher
Scientific) at a 1:10 dilution using 5 mm glass beads (Sigma-
Aldrich) in a TissueLyser II (Quiagen, MD, USA). Ten-fold serial
dilutions were plated on ALOA Agar plates (Biomérieux, France)
and incubated 2 days at 37°C prior to quantification of CFUs.
Additionally, bacteria were enriched by culturing fecal
homogenates for 24 h at 37°C in Half-Fraser broth followed by
plating on ALOA Agar Plates for qualitative evaluation. Ten-fold
serial dilution of milk probes were also plated on ALOA Agar
plates and enriched in Half-Fraser broth as described for fecal
samples. Bacterial isolates were confirmed by phenotype on
ALOA Agar plates (round, blue-green colony with an opaque
halo) and colony PCR amplification with the primer pairs hly_F/
hly_R, actA_F/actA_R, inlA_F/inlA_R, inlB_F/inlB_R, fosX_F/
fosX_R and NcSAG1_F/NcSAG1_R (Supplementary File S4).
CFU sensitivity was set at 103 CFU/gram feces or milk for the
quantitative assay without prior enrichment and at 102 CFU/
gram feces or milk for the qualitative assay after enrichment in
Half-Fraser broth followed by plating on ALOA Agar plates.
For assessment of bacterial intra-host spread, organs of female
mice (experiments 1-3) and pups (experiment 2) were collected
under sterile conditions immediately after euthanasia to evaluate
the presence of Lm in organs. Organs were divided for
immersion-fixation in 4% formaldehyde (for subsequent
histological and immunohistological analysis) and for
homogenization and enrichment in Half-Fraser Broth (1:10) asFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7described previously for fecal analysis. Additionally, in
experiment 3, pups which died in the postnatal phase (before
endpoint analysis), were weighted and homogenized in whole in
Half-Fraser broth (1:10) using an ULTRA-TURRAX® Tube
Drive (Faust AG, Schaffhausen, Switzerland) and serial
dilutions were plated on ALOA plates with and without prior
enrichment in Half-Fraser broth as described above for
qualitative and quantitative evaluation. At endpoint analysis,
three weeks after birth, spleen, part of the liver and the
gastrointestinal tract (GIT) of every surviving pup were pooled,
weighted and homogenized 1:10 in Half-Fraser broth for
quantitative and qualitative CFU evaluation as described above.
Histopathological Analysis
To screen for organ lesions caused by Lm WT and Lm3Dx_SAG1,
formalin fixed and paraffin embedded muscle, liver, spleen, brain,
kidney and uterus of adult mice used in all three experiments were
stained with hematoxylin and eosin (H&E) and microscopically
analyzed. In experiment 2, histopathology of spleen, liver
and GIT of pups was performed. Additionally, most sections
were screened for persistence of the vaccine vector by using
an immunohistochemical protocol for detection of Listeria.
Immunohistochemistry was performed as previously described
(Oevermann et al., 2010) with a polyclonal rabbit antibody
against Listeria (1:200, Difco Laboratories, Detroit MI, USA).
Assessment of the Immune Response
Against NcSAG1
To investigate the cellular immune response against Lm3Dx_SAG1,
spleens of female mice from the PBS and the different
Lm3Dx_SAG1 groups of experiments 1 and 3 were used for
splenocyte re-stimulation assays. Following euthanasia, spleen
samples were immersed in 5 mL of complete RPMI medium
(RPMI 1640 medium containing 1% antibiotic: 100 U of
penicillin, 100 ml of streptomycin, 2 mM L-glutamine, 10% FCS
and 55 mM b-mercaptoethanol). Splenocyte isolation was
performed as previously described (Aguado-Martıńez et al.,
2016a). Following lysis of red blood cells and two washing steps
with complete RPMI medium, cell suspensions containing the
splenic lymphocytes were seeded in a 24-well plate at a density of
2 x 106 cells/well.
Ex vivo stimulation of the seeded splenic lymphocytes was
performed with concanavalin A (ConA; 5 mg/mL; Sigma-
Aldrich) as positive control, with N. caninum antigen lysate
(20 mg/mL) or recombinant NcSAG1 (20 µg/mL), respectively.
Unstimulated splenocytes were used as negative control.
Following culture at 37°C/5% CO2 during 72 h, medium
supernatants of stimulated and unstimulated splenocytes were
collected and levels of IFN-g and IL-5 were measured in the
supernatants using the BD OptEIA™ mouse ELISA kits (BD
Biosciences, CA, USA) according to manufacturer’s instructions
(Aguado-Martıńez et al., 2016a). A Luminex instrument (Bio-
PlexTM 200 system) was used to run the microtiter filter plates.
The expression and purification of recombinant NcSAG1 used
for stimulation in our experiments was performed as follows. Firstly,
the coding sequence of NcSAG1 was cloned in the pET151 TOPO®
expression construct (ThermoFisher Scientific, MA, USA).NcSAG1August 2021 | Volume 11 | Article 675219
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strain and purified afterwards by Ni2+ affinity chromatography. For
the purification of NcSAG1 Protino®Ni-IDA 1000 packed columns
(Macherey-Nagel, Düren, Germany) were used, and proteins were
purified under denaturing conditions according to manufacturer’s
instructions. Purity of NcSAG1 was confirmed by SDS-PAGE and
the protein concentration was measured with a BCA Protein Assay
Kit (Pierce™).
To determine the humoral response against NcSAG1 in
experiment 1 blood samples were collected from the tail vein
one day before each immunization and by cardiac puncture 14
days after the 2nd booster, immediately after euthanasia. Blood of
theWT group was sampled only prior to the first inoculation and
immediately after euthanasia (Table 1). In experiment 3, to avoid
stress of pregnant dams, blood was sampled only two days prior
to the first vaccine application and following euthanasia, 42 days
after the second booster. Blood of surviving pups was also
collected by cardiac puncture. Anti-NcSAG1 IgG levels were
determined by ELISA according to Debache et al. (Debache et al.,
2008). In brief, 96-well plates were coated with recombinant
NcSAG1 (100 ng/well) and incubated overnight at 4°C. The
following day, plates were washed three times with washing
buffer (0.05% PBS-Tween-20) before antigens were blocked with
1% bovine serum albumin (BSA) in 0.05% PBS-Tween-20 for 2h
at RT. Subsequently, sera of individual mice at a dilution of 1:50
and two-fold sequential dilution up to 1:400 were added to
individual wells. Following three washes, secondary antibody
(goat anti-mouse IgG conjugated to AP (Promega)) was applied
at a dilution of 1:2000. Development was performed with AP
substrate buffer (1mg/mL). Absorbance was measured as optical
density (OD) at 405 nm in a microplate reader (EnSpire™ 2300
Multilabel Reader, Switzerland). For evaluation, OD values were
converted into relative index per cent (RIPC) values using the
following formula [RIPC = (OD405nm sample – OD405nm
negative control)/(OD405nm positive control – OD405nm
negative control)*100 (Aguado-Martıńez et al., 2016b). Serum
of Nc infected mice was used as positive control.
Statistical Analysis
Differences in arithmetic means of CFU between mutants and
JF5203 were evaluated with the parametric student t-test and of
the humoral and cellular immune responses between mice groups
were compared with the non-parametric Mann-Whitney-U test.
For the temporal analysis of the IgG response a one-way ANOVA
repeated measure was used to compare each timepoint within
each given group. 95% confidence intervals (95%CI) were
determined and statistical significance was assigned as follows:
P ≤.032 *, P ≤.0021 **, P ≤.0002 ***, P <.0001****. For IFN-g and
IL-5 concentrations, graphs are presented as column charts.
Pup mortality was analyzed with the Kaplan–Meier survival
method. Pup survival curves were then compared by the Log-
rank (Mantel–Cox) test, and differences in pup’s mortality rates
between groups were assessed by the c2 or Fisher’s exact test.
All statistical analysis were performed using the commercially
available software Prism 9 (Graphpad Prism version 9.0.2 for
MacOSX, GraphPad Software, La Jolla, CA, USA, www.
graphpad.com).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8RESULTS
Lm3Dx Is Strongly Attenuated in MDCK
Cells, but Behaves Similar to WT in Early
Stages of DH82 Cell Infection
The parental Lm JF5203 strain (lineage I, CC1, ST1) that was
isolated from a bovine rhombencephilitis case induces a strong T-
cell and B-cell response (Oevermann et al., 2010). It has been
extensively studied in our laboratory, and the complete genome has
been published and annotated (Aguilar-Bultet et al., 2018). To
evaluate the attenuation of the Lm3Dx strain and its tropism to
phagocytic cells, MDCK and DH82 were used as surrogates for
canine epithelial cells and APCs, respectively, and were infected with
Lm3Dx in comparison to WT JF5203, DactA, and the related
apathogenic bacterium Listeria innocua (Li) (Figure 1). In
MDCK cells, the vaccine strain behaved similarly to the
apathogenic Li and was significantly attenuated in cellular
invasion compared to WT and DactA Lm as indicated by 2.5
orders of magnitude lower CFUs at 2h pi (Figure 1A). Confirming
the CFU data, immunofluorescence microscopy detected clearly
lower number of intracellular bacteria and infection foci in Lm3Dx
than in WT and DactA (Supplementary File S7) at 2h pi.
Interestingly, Lm3Dx exhibited, similar to Li, a lag phase
compared to DactA and WT before the numbers of CFU raised
exponentially. Additionally, Lm3Dx reached its plateau phase at a
CFU count that was slightly higher than observed for Li but
approximately 2 and 4 orders of magnitude lower than CFUs of
DactA and WT, respectively (Figure 1A). The lower CFU plateaus
indicated deficient intercellular spread of Lm3Dx and DactA. This
was further supported by the small size of their infection foci and
lower number of intracellular bacteria compared to the WT at 24h
pi when analyzed with immunofluorescence microscopy
(Figure 1B). Also, no actin polymerization was observed in
Lm3Dx, DactA and Li, proving their inefficiency move
intracellularly as opposed to WT and to spread from cell-to-cell
(Figure 1B and Supplementary File S7). During long-term
infections, the Lm3Dx vaccine strain continued to follow the
infection kinetics of the apathogenic Li and was rapidly cleared in
MDCK cells. CFU of Lm3Dx were detected until 2 days pi, while
CFU of DactA and WT were retrieved in MDCK cells up to 7 days
and 14 days pi, respectively (Figure 1C).
In contrast to the infection in MDCK, infection dynamics of
Lm3Dx in DH82 cells were similar to the DactAmutant rather than
Li. This indicates (i) the insignificance of inlA and inlB for Lm
infection of phagocytic cells, and (ii) a stronger intracellular survival
of Lm3Dx in phagocytes compared to Li. CFU data at 2h pi
indicated that all strains entered DH82 cells with similar efficiency
(Figure 1D) which was supported by similar numbers of
intracellular bacteria and infection foci as visualized by
immunofluorescence microscopy at 2h (Supplementary File S8).
CFU numbers of Li remained constant for the first 6h and then
continuously dropped (Figure 1D). In contrast, CFU counts of
Lm3Dx increased until 6 h pi similar to WT and DactA reaching a
peak of 1 x 106 CFU/well (Figure 1D). Later, CFU of Lm3Dx and
DactA dropped by approximately one order of magnitude and fewer
intracellular bacteria were observed compared to the WT at 24 h
(Figures 1D, E). Within the following 48 h, the numbers of CFUsAugust 2021 | Volume 11 | Article 675219
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of CFUs in the WT started only at 48 h pi (Figure 1D).
Immunofluorescence microscopy revealed that Lm3Dx and DactA
had similar number and size of infection foci confirming CFU data
(data not shown). Infection foci were smaller than those in WT
infected DH82 and larger than those of Li. Lm3Dx had no visible
actin tails, indicating that it has lost the spreading ability (Figure 1E
and Supplementary File S8). The clearance of Lm3Dx in DH82Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9was similar to that of the DactA mutant. While both Lm3Dx and
DactA persisted in DH82 until 5 days pi, the WT was detected until
9 days pi (Figure 1F). Additionally, cell infection assays were
performed with the intermediate mutants DactA/fosX and DactA/
DinlB/DfosX (up to 72 h pi) and these mutants behaved as the DactA
mutant in DH82 andMDCK cells leading to the conclusion that cell






FIGURE 1 | Gentamicin protection assay with the wildtype (WT) parental strain JF5203 (black circles), DactA (blue square), Lm3Dx (orange triangle) and L. innocua
(red triangle) in an epithelial (A–C) and macrophage-like cell line (D–F). For the short-term assay until 72h, canine epithelial cells (MDCK) (A) and canine macrophage-
like cells (DH82) (D) were infected for 1h at a multiplicity of infection of 1.25:1. CFU were enumerated at the indicated time points. Immunofluorescence microscopy
images of MDCK (B) and DH82 (E) at 24h post infection with the parental strain, mutants and L. innocua. Bacteria are shown in green (Listeria-Antibody), cellular
actin is stained with fluorescent phalloidin (red) and cellular and bacterial nuclei with DAPI. At 24h the number of intracellular bacteria is strongly reduced in Lm3Dx-
infected MDCK compared to WT-infected and DactA-infected MDCK, and rather similar to L. innocua-infected MDCK (B). Additionally, Lm3Dx lacks actin
polymerization, which is prominent in the WT infected cells (red comet tails). The number of intracellular bacteria is higher in Lm3Dx-infected DH82 cells (D) and the
reduction compared to WT is less evident than in MDCK. For the long-term assay until 14d, MDCK (C) and DH82 (F) cells were infected for 1h at a multiplicity of
infection of 1.25:1. At the indicated timepoints, cells were detached by trypsin and 50% of cells were transferred to a new well. The remaining cells were lysed and
serial dilutions were plated for CFU counting on BHI-Agar. Lm3Dx is cleared more rapidly than the WT from both epithelial and macrophage-like cells. Datapoints in
the graphs are from 3 independent experiments performed in triplicate wells and are presented with ± 95% confidence interval; *P<0.05, ***P<0.001,
****P<0.0001 (student t test). Because the y-axes of the graphs are in log scale, below detection level (BDL) was added manually to show all values where no CFU
were recovered.August 2021 | Volume 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based VaccineIn summary, in vitro results showed strong attenuation of
Lm3Dx in epithelial cells due to significantly reduced cellular
invasion and intercellular spread, while the same strain behaved
identical to the WT within phagocytic cells during the early stage
of infection as further supported by the number of generations
between 2-6h (Supplementary File S5).
The Genome of Lm3Dx Remains Stable for
100 Passages After Deletions
Stability of actA, inlA, inlB and fosX deletions was confirmed by
PCR every 10th passage in BHI (data not shown) up to passage
number 100 (Figure 2). Additionally, analysis of entire genomic
sequences of Lm3Dx at passages 1 and 100 revealed that the
genome was stable except the appearance of one SNP identified
in the nifJ gene, resulting in an isoleucine substituting a
methionine (G2752A) in the encoded oxidoreductase. No
difference was detected in the infection phenotype of passage
100 in the tested cell lines compared to the initial Lm3Dx
mutant, and likewise fosfomycin sensitivity with a MIC of 6
µg/mL compared to ≥1024 µg/mL in the WT was maintained
after 100 passages (Supplementary File S6).
Lm3Dx Expresses NcSAG1 at the RNA and
Protein Level
Based on the in vitro results, we anticipated that Lm3Dx would
not be able to cause systemic infection of epithelial organs in vivo,
but that the early infection dynamics of Lm3Dx in phagocytes
would be sufficient to trigger an efficient immune response.
Therefore, as a proof of concept we created Lm3Dx_SAG1 by
inserting the Neospora caninum sag1 sequence fused to the first
300 nucleotides of actA into the actA locus of Lm3Dx, and
confirmed NcSAG1 expression in Lm3Dx_SAG1 on RNA
(Figure 3A) and protein level (Figure 3B).
In Vivo Safety Assessment and
Immunological Characterization of the
Lm3DX Vaccine Strain Expressing the
Major N. caninum Surface Antigen
NcSAG1
None of the Lm3Dx_SAG1 vaccinated mice developed adverse
events or clinical signs of listeriosis after vaccination in any of theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10mouse experiments. In experiment 1, fecal shedding of
Lm3Dx_SAG1 was detected only following enrichment in 3/6
mice from the 5 x 106 CFU dose group and 1/6 mice from the 1 x
107 CFU dose group at day 1 pi. Furthermore, in the 1 x 107
CFU/mice group, Lm3Dx_SAG1 was recovered following
enrichment at day 3 and day 7 after the first booster injection
in one mouse each. In contrast to the Lm3Dx_SAG1 groups,
mice injected with the parental WT strain exhibited clinical signs
early on. Initial signs appeared 12 h pi and were characterized by
mildly reduced general condition and slightly mat fur, while
behavior remained normal. However, at 36 h pi, all mice
inoculated with the Lm WT strain exhibited strongly impaired
health status (isolation, lethargy, hunched posture, ruffled fur,
ataxia, paralysis of the injected hindlimb) and had to be
humanely euthanized. Feces of WT infected mice were positive
only after enrichment in 2/6 mice one day pi, while at day 2, feces
of 5/6 mice contained high numbers of bacteria (mean 4.95 x 106
CFU/gram feces ± 4.76 x 106 (SD)). The feces of one mouse were
not recovered at day 2 pi. Feces of sentinel mice in all Lm3Dx
groups and the WT group remained negative for Lm throughout
the experiment.
After euthanasia of WT injected mice at 36h after injection,
CFU count revealed high bacterial loads in most organs
(Figure 4A). The highest bacterial loads were found in the
spleen (mean 2.0 x 1010 CFU/gram) and liver (mean 1.62 x 107
CFU/gram), while in kidney (mean 4.34 x 104 CFU/gram), uterus
(mean 5.72 x 104 CFU/gram) and brain (mean 2.64 x 104 CFU/
gram) bacterial numbers were lower (Figure 4A). In contrast, at
the same timepoint post inoculation, Lm3Dx_SAG1 was
recovered only from the spleen of 3/5 mice at a mean 8 x 103
CFU/gram organ, 7 orders of magnitude lower than the WT
(Figure 4A). No Lm3Dx_SAG1 was detected in any other organ
36h after injection, not even following overnight enrichment in
broth (Figure 4A).
In experiment 2, Lm3Dx_SAG1 excretion into milk of
lactating mice was followed up to day 4 post vaccination
(Figure 4B). Bacterial numbers reached 2.96 x 106 CFU/ml of
milk at day 2 and remained high until day 4 (Figure 4B).
Additionally, Lm3Dx_SAG1 was isolated in relatively high
numbers from the GIT of pups at day 4 (mean 1,81 x 104
CFU/gram) indicating that bacteria were taken up orally with theFIGURE 2 | PCR for hly, actA, inlA, inlB and fosX of WT, Lm3Dx and intermediate mutants at passage 100. All strains harbor the hly gene encoding for Listeriolysin
O that was used as species control for Listeria monocytogenes. Deletions of actA, inlA, inlB and fosX are stable across 100 passages.August 2021 | Volume 11 | Article 675219
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transmitted with the dam’s milk to the pups, none of the pups
showed clinical signs of listeriosis. Furthermore, Lm3Dx_SAG1
generally remained restricted to the GI tract of the pups and did
not cross the gastrointestinal barrier as indicated by the low
incidence of bacteria in internal organs: Lm3Dx_SAG1 was
found only following enrichment in the spleen and liver of
only 1 and 4/43 pups, respectively (Figure 4C). In line with
clinical and CFU data, no histopathological lesions were
observed in the GIT and internal organs of pups (data not
shown). Interestingly, IHC revealed only very few bacteria in
the GIT lumen of 5/43 pups, which is in line with the low
number of recovered CFU from the GIT. Also in lactating dams,
Lm3Dx_SAG1 was isolated from single animals and at low
numbers from GIT, spleen and liver at 4d post inoculation
(Figure 4D). Importantly, at two weeks after the third
inoculation (experiment 1) no Lm3Dx_SAG1 was isolated
from any organ indicating that the vector is cleared during this
time interval (Figure 4E).
The differences in bacterial load of the Listeria monocytogenes
target organs liver, spleen, brain and uterus were reflected in the
variation of pathology between WT and Lm3Dx_SAG1. All mice
of the WT group suffered severe hepatitis and splenitis with
necrosuppurative lesions containing large number of Listeria at
36h, while no significant lesions were present in the liver and
spleen of Lm3Dx_SAG1 vaccinated adult mice at this time point
(Figures 5, 6). Similarly, at later time points (4 days, 2 and 6
weeks post inoculation), no lesions were observed in the target
organs, independently of the physiological status of mice
(lactation or pregnancy at vaccination). Immunohistochemistry
revealed multifocal positivity in few scattered inflammatory cells
within the spleen (Figures 6G, H), but not in the liver (Figure 5),
of 4/5 and 4/7 mice at day 1.5 (experiment 1) and 4 (experiment
2), respectively. However, clear bacterial structures were only
rarely present (Figure 6H). At later time points, no signal was
observed anymore. At the site of i.m. injection, all WT inoculated
mice showed at 36h large and severe necrosuppurative foci in the
muscle, containing myriads of bacteria within phagocytes and
myofibers (Figures 7A, F). In contrast, Lm3Dx_SAG1-injectedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 11mice exhibited a prominent inflammation in the thigh, which
was mainly restricted to the subcutaneous and intermuscular fat
tissue and occasionally extended between muscle fibers
(Figure 7B). Myofiber necrosis, which was a prominent feature
in the WT group (Figure 7A), was rarely observed in the
Lm3Dx_SAG1 group. The cellulitis and interstitial myositis
was self-limiting in the Lm3Dx_SAG1 group. At day 4
following injection (experiment 2, Figure 7C), all lactating
mice vaccinated with 1 x 107 CFU Lm3Dx_SAG1 had myositis
at the site of inoculation in the thigh muscle characterized by
focal to multifocal interstitial infiltrations with moderate
numbers of neutrophils and fewer macrophages. At two weeks
following the third injection (experiment 1, Figure 7D), severity
of myositis was decreased consisting of mild focal interstitial
lymphohistiocytic inflammatory infiltrates in 5/6, 6/6 and 6/6
mice of the 1 x 106 CFU, 5 x 106 and 1 x 107 CFU group,
respectively. By 6 weeks following the third injection
(experiment 3, Figure 7E), the thigh muscle was free of
inflammation at the injection site. Interestingly, using
immunohistochemistry no bacteria were observed in the
interstitial infiltrate of adult mice at 1.5d following vaccination
with 1 x 107 CFU Lm3Dx_SAG1 (Figure 7G). Only in 1/5
mouse, a positive signal was detected in a few cells of the
popliteal lymph node (Figure 7G insert). However, when
mice were vaccinated during early lactation with 1 x 107 CFU
Lm3Dx_SAG1, moderate numbers of bacteria were multifocally
observed in the interstitial infiltrate (Figure 7H). At two
weeks following the third injection, immunohistochemistry
for Listeria revealed few bacteria and/or fragments in
inflammatory cells of 4/6, 5/6 and 3/6 mice in the 1 x 106
CFU, 5 x 106 and 1 x 107 CFU group, respectively (Figure 7I).
At 6 weeks following the third injection, no bacteria were
detected neither with immunohistochemistry (Figure 7J) nor
with bacteriology.
The potential effect of vaccination on fertility and pregnancy
outcome was evaluated and is summarized in Table 2.
Vaccination of pregnant mice had no negative impact on the
fertility or the number of viable pups. While in the PBS control
group one out of 21 pups born died in the neonatal phase, 1/28A B
FIGURE 3 | NcSAG1 expression by Lm3Dx_SAG1. (A) NcSAG1 mRNA expression. The 200 bp band of NcSAG1 is visible in Lm3Dx_SAG1 (1), but not in the
empty vector Lm3Dx (3). H20 was used as negative control (2) and pMAD_NactA100AA_SAG1 plasmid DNA as positive control (4). (B) Bacterial NcSAG1 protein
expression in infected cells. WB evidences a specific band of NcSAG1 protein expression at 35kDa in DH82 cells infected with Lm3Dx_SAG1HIS (2) and
Lm3Dx_SAG1 (3), but not in DH82 cells infected with the empty vector Lm3Dx (4). Nc crude extract was used as positive control (1).August 2021 | Volume 11 | Article 675219
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and 1 x 107 CFU group, respectively (P > 0.05) (Table 2).
Furthermore, vaccination of mice during pregnancy did not
negatively impact the development of pups in any of the
immunized groups.
Lm3Dx_ SAG1 Triggers a Th1-Biased
Immune Response in Both the Non-
Pregnant and Pregnant Mouse Model
Vaccination of non-pregnant mice with Lm3Dx_ SAG1 induced
a strong Th1 biased immune response when compared to the
PBS control group. Comparison to the WT group was notFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12possible, because all WT mice had to be euthanized within
36 h after the first inoculation. We found higher IFN-g
production in splenocytes isolated from spleens of the 1 x 106
and 5 x 106 CFU of Lm3Dx_ SAG1 vaccinated group compared
to the group inoculated with PBS (Figure 8A). The IFN-g
response was negatively correlated with the inoculation dose,
being strongest in the low-dose group (1 x 106 CFU) and lowest
in mice vaccinated with 1 x 107 CFU. In the latter group, the
IFN-g response was not significantly different to the PBS control
group (Figure 8A). IFN-g production was variable between
individuals of each group with responses ranging from 5 x 103




FIGURE 4 | Recovery of WT and Lm3Dx_SAG1 L. monocytogenes from internal organs and milk. (A) Mean ± SEM CFU/gram organ in adult non-pregnant mice
36h following i.m. inoculation with 1 x 107 WT or Lm3Dx_SAG1. Asterisks indicate significant differences to the WT group: **P ≤ 0.0021 (Mann Whitney-U test).
(B) Excretion of Lm3Dx_SAG in milk during 4 days following i.m. vaccination of lactating dams, given as mean ± SEM CFU/ml (experiment 2). (C) Mean ± SEM CFU/
gram organ of pups feeding milk from Lm3Dx_SAG1 dams (experiment 2). (D) Mean ± SEM CFU/gram organ in lactating dams 4 days following vaccination with 1 x
107 Lm3Dx_SAG1 (experiment 2). (E) No CFU were recovered from internal organs of adult mice two weeks following the third vaccination with Lm3Dx_SAG1
(experiment 1). The data points represent individual mouse values. The detection limit for all experiments was set to 102 CFU/gram organ or milk following
enrichment (dashed line). BDL, Below detection limit.August 2021 | Volume 11 | Article 675219
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were significantly higher than the PBS group (Figure 8B).
In the pregnancy outcome model (experiment 3), stimulated
splenocytes isolated from spleens of both, dams and non-
pregnant mice, produced increased IFN-g. No difference inFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 13IFN-g response was observed between pregnant and non-
pregnant animals (Figure 8C). Similarly to experiment 1, IL-5
levels were increased in Lm3Dx_ SAG1 vaccinated mice
compared to the PBS group, albeit at much lower amounts
than IFN-g (Figure 8D). For unknown reasons, cytokineFIGURE 6 | Representative HE (A–E) and immunohistochemically (antibody against Lm) (F–J) stained spleen tissue of WT- and Lm3Dx_SAG1- injected mice.
(A) Coalescing necrosuppurative foci in the red pulp of the spleen (asterisks) in mice at 36h following injection with WT Lm (100x magnification). (B–E) Spleens of
mice injected with 1 x 107 Lm3Dx_SAG1 are normal, without lesions of necrosuppurative splenitis at all time points: (B) 1.5d (100x magnification) and (C) 4d (40x
magnification) following inoculation, (D) 14d (40x magnification) and (E) 46d (40x magnification) following the second boost injection. (F) Necrosuppurative foci
contain numerous bacteria at 1.5d following inoculation with WT Lm (400x magnification). (G) At 1.5d following Lm3Dx_SAG1 injection, 4/5 mice contained multifocal
inflammatory cells of the splenic red pulp with a positive Lm signal (arrow), but no clear bacterial structures were observed (200x magnification). (H) At 4d following
Lm3Dx_SAG1 injection, 4/7 lactating mice contained multifocal inflammatory cells of the splenic red pulp with a positive Lm signal (arrows), and additionally
elongated positive structures compatible with bacteria (400x magnification). (I) At 14d (200x magnification) and (E) 46d (100x magnification) following the second
boost injection, no positive signal was observed in Lm3Dx_SAG1 injected mice.FIGURE 5 | Representative HE (A–E) and immunohistochemically (antibody against Lm) (F–J) stained liver tissue of WT- and Lm3Dx_SAG1- injected mice.
(A) Multifocal necrosuppurative hepatitis (arrows) in mice at 36h following injection with WT Lm (40x magnification). Inset: 400x magnification of a small hepatic
abscess with aggregations of neutrophils obliterating hepatic cords. (B–E) Livers of mice injected with 1 x 107 Lm3Dx_SAG1 are normal, without lesions of
necrosuppurative hepatitis at all time points: (B) 1.5d (100x magnification) and (C) 4d (40x magnification) following inoculation, (D) 14d (40x magnification) and
(E) 46d (40x magnification) following the second boost injection. (F) Necrosuppurative foci contain myriads of bacteria at 1.5d following inoculation with WT Lm
(400x magnification). (G–J) Livers of mice injected with 1 x 107 Lm3Dx_SAG1 do not contain any bacteria throughout the experiment: (B) 1.5d (100x magnification)
and (C) 4d (100x magnification) following inoculation, (D) 14d (200x magnification) and (E) 46d (200x magnification) following the second boost injection.August 2021 | Volume 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based Vaccineconcentrations were higher than in the first experiment. Factors
that may have contributed to the variation might include 1)
sample freezing and thawing in experiment 1, which may have
led to protein degradation; 2) time point differences: blood
samples in experiment 3 were collected three weeks later than
in the first experiment, and in this time window the cellular
immune response may have further matured; 3) inter-
experimental variation.
Lm3Dx_ SAG1 Elicits a Low-Titer Nc
Specific IgG Response in Both Non-
Pregnant and Pregnant Mice
Lm3Dx_SAG1 triggered only low titers of NcSAG1 specific IgG.
In experiment 1, when compared to the baseline titers of animals
before vaccination, a significant increase of IgG titers was only
observed following the second booster in the 1 x 107 CFU groupFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 14(Figure 9A). Compared to the PBS group, NcSAG1-specific IgG
titers were significantly higher in Lm3Dx_SAG1 vaccinated
animals of al l dose groups from day 28 fol lowing
primovaccination (Figure 9A). However, titers remained low
compared to the positive control (2-15% of IgG titer in serum of
Nc infected animals) and similar as the IFN-g response, titers
were variable between individuals.
Also in the pregnancy interference test (experiment 3), a mild
increase of NcSAG1 IgG antibody titers was observed, but as
opposed to experiment 1 only in animals following vaccination
with 1 x 106 CFU/mouse (2.5% of IgG titer in serum of Nc
infected animals, Figure 9B). The mean antibody titers that were
determined in the 1 x 106 CFU groups in experiment 1 and 3
were similar (2.4 ± 3.4 and 2.7 ± 3.7 respectively) but differed in
the 1 x107 CFU groups (14.7 ± 17.8 and 0.6 ± 2.6, respectively).
Although the difference in antibody titers between offspring fromTABLE 2 | Data of the pregnancy outcome experiment (experiment 3). Mice received 3 doses of either 1 x 106 CFU Lm3Dx_SAG1, 1 x 107 CFU Lm3Dx_SAG1 or PBS.






Postnatal mortality [%] Postnatal survival [%]
106 CFU 4/6 66.7 28 2/28 7.1 0/26 0.0 100.0
107 CFU 3/6 50.0 21 3/21 14.3 0/18 0.0 100.0
PBS 3/6 50.0 21 1/21 4.8 0/20 0.0 100.0August 2021 | VoluFIGURE 7 | Representative HE (A–E) and immunohistochemically (with antibody against Lm) (F–J) stained muscle tissue of representative WT- and Lm3Dx_SAG1-
injected mice. (A) Severe necrosuppurative myositis with marked neutrophilic infiltration (asterisks) and multifocal severe myofiber necrosis (arrowheads) is present in
the thigh musculature of WT injected mice at 1.5d after inoculation (100x magnification). (B) Focal-extensive and prominent infiltration of the intermuscular fat tissue
with neutrophils and macrophages (asterisk) that extends into the muscular interstitium (open arrow) in a mice at 1.5d following injection with 1 x 107 Lm3Dx_SAG1
(100x). No myofiber necrosis is present. (C) Focal infiltrate with moderate numbers of neutrophils and macrophages (asterisk) that is restricted to the interstitial space
between muscle fibers of the thigh musculature in a lactating mouse at 4d following inoculation with Lm3Dx_SAG1 (100x magnification). No myofiber necrosis is
present. (D) Mild lymphohistiocytic infiltrates (asterisk) are present between muscle fibers of the thigh musculature of mice at 14d following the last boost with
Lm3Dx_SAG1 (200x magnification). No myofiber necrosis is present. (E) At 46 days following the second boost with Lm3Dx_SAG1, the thigh muscle is free of
inflammatory infiltrates (200x magnification). (F) Myriads of bacteria are observed in myofibers (arrow) and within neutrophils (open arrowheads) at 1.5d following
inoculation with WT (200x magnification). Arrowhead indicates necrotic myofiber. (G) At day 1.5 following inoculation of adult mice, no bacteria are observed in the
interstitial infiltrate (asterisks, 400x magnification). One/5 mice had a positive signal in the popliteal lymph node (inset, 400x magnification). (H) At day 4 following
inoculation of lactating mice with Lm3Dx_SAG1, interstitial infiltrates contain moderate numbers of bacteria (400x magnification). Neighboring myofibers are normal.
(I) Few inflammatory cells within the interstitial infiltrates contain bacteria (open arrowhead) or bacterial fragments at 14 days following the second boost with
Lm3Dx_SAG1 (400x magnification). (J) No bacteria are present in the thigh muscle of LM3Dx_SAG1 injected mice at 46 days following the second boost (200x
magnification).me 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based Vaccinedams vaccinated with 1 x 106 CFU/mouse and from non-
vaccinated dams was significant, the titers were very low
compared to titers of Nc-infected animals (Figure 9C). In
summary, the Nc specific IgG response was very low in all
vaccinated animals.DISCUSSION
Over the past 20 years, a growing body of evidence has shown
that Lm modulates the immune response and is highly amenable
to genetic manipulation, and thus constitutes a promising
vaccine vector for prevention and therapy of cancer and
infectious diseases (Flickinger et al., 2018). We demonstrate
the safety of the highly attenuated Lm vaccine vector
Lm3Dx_NcSAG1, which is devoid of any exogenous antibioticFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 15resistance gene, in adult mice and provide first evidence of
its immunogenicity.
Notwithstanding the claimed safety of previously developed
Lm-based vaccine vectors with either single (DactA, DprfA) or
double (DactA/DinlB) virulence gene deletions, several reports
have indicated sporadic side effects post-vaccination, and isolated
cases of vaccine-induced acute and delayed listeriosis have been
described in humans and dogs (Maciag et al., 2009; Sacco et al.,
2016; Denham et al., 2018; Fares et al., 2019). Indeed, even though
prfA is the regulator of most of the virulence genes, inlA and inlB
are also regulated by sigB (Kim et al., 2005), which may explain
why the DprfA knock-out mutant used was not fully attenuated
and may have been able to cause adverse effects upon infection.
Therefore, we created an antibiotic-resistance-free triple deletion
mutant devoid of actA, inlA and inlB to minimize the likelihood
of systemic infection. Deletion of actA causes a 1000-fold LD50A B
DC
FIGURE 8 | IFN-g and IL-5 response in Lm3Dx_SAG1-immunized mice. (A) IFN-g and (B) IL-5 response of splenocytes isolated from spleens 14 days after the
second boost of non-pregnant mice. Splenocytes were stimulated with recombinant NcSAG1 or Neospora caninum crude extract (grey bars). (C) IFN-g and (D) IL-5
response upon stimulation in the pregnancy outcome model. In this experiment, splenocytes of mice were recovered 42 days after the second boost or sham (PBS)
injection. Columns represent the median and whiskers the standard deviation. * indicate significant levels compared to the PBS group: *P ≤ 0.0332, **P ≤ 0.0021
(Mann Whitney-U test).August 2021 | Volume 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based Vaccineincrease of Lm via prevention of bacterial intercellular spread
and, hence, systemic dissemination of infection, and additionally
via promotion of autophagy (Flickinger et al., 2018; Radoshevich
and Cossart, 2018; D’Orazio, 2019; Chávez Arroyo and Portnoy,
2020). Co-deletion of actA and inlB results in a safe vaccine vector
by preventing hepatocyte infection and systemic spread while
eliciting a potent immune reaction upon injection (Brockstedt
et al., 2004; Flickinger et al., 2018). To further increase safety, we
deleted two additional genes in Lm JF5203 generating the vector
Lm3Dx: inlA to prevent infection of E-cadherin expressing tissues
(Lecuit et al., 1997) and fosX to increase fosfomycin-sensitivity in
vitro and in vivo (Scortti et al., 2018). In vitro fosfomycin
resistance is an inherent feature of Lm and genetically encoded
by fosX (Scortti et al., 2018). Therefore, in vitro sensitivity to
fosfomycin can be used as a rapid phenotypical marker to
discriminate the Lm3Dx vaccine vector lacking fosX from
naturally occurring Lm. Moreover, fosX deletion further
increases fosfomycin sensitivity of Lm in vivo (Scortti et al.,
2018), and, therefore, fosfomycin becomes a potent alternative
antibiotic to the commonly used ampicillin-gentamicin
combination for elimination of potentially persisting bacteria
after completion of the vaccination protocol and for therapy in
case of post-vaccinal infection (Maciag et al., 2009; Basu et al.,
2018; Safran et al., 2018).
Our in vitro results provided sufficient evidence of i) low risk
of undesired systemic infection and persistence due to impaired
epithelial cell infection and ii) sufficient APC targeting, to
continue to test the vector safety in vivo. Additionally, we
investigated the immune response against NcSAG1 in these
experiments as a proof of concept by expressing the highly
immunogenic Neospora caninum tachyzoite antigen in Lm3Dx.
In contrast to most existing Lm vaccine platforms that rely on
integration plasmids for antigen complementation (Lauer et al.,Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 162002; Zebertavage et al., 2019), the gene coding for NcSAG1 was
inserted by homologous recombination for two reasons. First, we
wanted to avoid introduction of an exogenous antibiotic
resistance gene. Although the use of integration plasmids
allows rapid insertion of exogenous genes, the entire plasmid
sequence containing antibiotic resistances genes allowing
for selection is integrated into the vector genome at a
predetermined site and retention in the bacterial genome
requires propagation of the vaccine vector in selective media
containing antibiotics or other selective components (Lauer
et al., 2002). In contrast, when using suicidal homologous
recombination plasmids, the antibiotic resistance gene is
removed from the vaccine strain with the plasmid at the end
of the cloning process. Furthermore, the use of a Lm vector
lacking fosX such as Lm3Dx allows the complete abandonment
of exogenous antibiotic resistance genes during cloning with
recombination plasmids containing fosX. Secondly, we aimed to
ensure insertion of the sag1 gene into the actA locus, thus
allowing for strong antigen expression in vivo to be regulated
by the natural actA promotor, which is strongly activated by prfA
during in vivo infection (Radoshevich and Cossart, 2018).
Additionally, the gene integration is stable and does not
require growth on selective media for maintenance. While
others used homologous recombination plasmids for
complementation (Frankel et al., 1995; Friedman et al., 2000),
they did not insert the target antigen into the actA locus.
Throughout all in vivo studies employing the Lm3Dx_SAG1
vaccine, neither clinical signs nor adverse effects were observed,
which was in contrast to WT injected mice. This is in accordance
with the previously reported LD50 of 10
8 CFU in a DactA/DinlB
mutant (Brockstedt et al., 2004). Additionally, only few injected
mice shed Lm3Dx_SAG1 in the feces, and only at a very low
level. Furthermore, no lesions were detected in Lm target organsA B C
FIGURE 9 | Antibody titers in Lm3Dx_SAG1-immunized mice. (A) NcSAG1 IgG in Lm3Dx_SAG1-immunized non-pregnant mice (experiment 1; 1 x 106, 5 x 106 or
1 x 107 CFU/mice dose groups). Naïve mice (PBS) were included as negative control for each time point of measurement. (B) NcSAG1 IgG response in
Lm3Dx_SAG1-immunized mice in the pregnancy outcome model (experiment 3; 1 x 106 and 1 x 107 CFU/mice dose groups, empty triangle, square or circle = non-
pregnant mice, filled triangle, square or circle = pregnant mice). Naïve mice (PBS) were included as negative control for each time point of measurement. Sera were
taken 3 days prior to primary vaccination (Day -3) and 42 days after the 2nd booster administration (74 days following primary vaccination, Day 74). (C) NcSAG1 IgG
response in pups born from Lm3Dx_SAG1-immunized dams in the pregnancy outcome model (experiment 3; 1 x 106 and 1 x 107 CFU/mice dose groups). Sera
were taken three weeks after birth during euthanasia and compared to sera from pups born from PBS vaccinated dams. Results are expressed as the mean of RIPC
(relative index per cent) in relation to the positive control (serum of Nc infected mice), and error bars represent the standard error of the means (S.E.M) in each group.
*P ≤ 0.0332, **P ≤ 0.0021 (Mann Whitney-U test).August 2021 | Volume 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based Vaccinesuch as spleen or liver, and the local inflammation at the
injection site in the thigh muscle resolved by itself within 6
weeks following the last injection as observed in histology and
immunohistochemistry. Furthermore, transmission of
Lm3Dx_SAG1 to sentinel mice was not observed. Altogether,
these results suggest that Lm3Dx_SAG1 is not shed to a
significant level into the environment via feces and does not
persist in the immunocompetent host, which is of importance in
the view of reported intravacuolar persistence and delayed
infections following vaccination (Kortebi et al., 2017). Our
observations including the extremely low shedding into the
environment, absence of pregnancy interference, absence of
clinical signs and target organ lesions as well as absence of
persistent bacteria 42 days after the last boost indicates that the
Lm3Dx vaccine vector exhibits a high safety level in adult non-
lactating mice and, therefore, can be tested in other animal
species including ruminants and dogs, susceptible hosts for
Neospora caninum. It was surprising that Lm3Dx_SAG1 was
excreted at considerable number into the milk when given to
lactating mice. However, milk shedding was not associated with
any clinical signs in neither dams nor pups, even though
Lm3Dx_SAG1 was taken up by suckling pups with the milk.
Crossing of the GIT barrier and colonization of internal organs
was rarely observed in pups and only at very low levels. In line
with these results, no histopathological lesions were observed in
internal organs of pups. Sporadic crossing in some pups could be
due to increased permeability of the GIT due to open tight-
junctions at young age (Duffy, 2000; Nguyen et al., 2001; Gleeson
et al., 2021). Alternatively, Lm3Dx_SAG1 might have reached
internal organs via uptake into APCs and macrophages probing
the GIT (Macpherson and Uhr, 2004). It was also surprising that
while immunohistochemistry failed to detect Lm3Dx_SAG1 in
the thigh muscle of non-lactating mice at 1.5d after vaccination,
bacteria were still observed at day 4 in lactating mice, indicating
impact of the physiological status on bacterial clearance. Milk
contamination and prolonged persistence of bacteria in the
muscle may be avoided by vaccinating lactating animals during
the dry period or by implementing post-vaccination treatment
with fosfomycin to ensure complete elimination of bacteria.
However, our observations claim further investigations into
mechanisms of milk excretion, impact of lactation on vector
dynamics in the host and the safety of vector use during lactation
before vaccination of lactating large animals is considered.
Lm infection triggers innate as well as adaptive immune
responses (Wallecha et al., 2012; Flickinger et al., 2018;
D’Orazio, 2019). Our preliminary data showing a strong IFN-g
production and low IgG responses point towards a Th1-
biased immune response against NcSAG1. However, responses
among individual mice of the same dose group varied, and not all
mice developed immunity. External and internal factors such as
those reported in humans (Zimmermann and Curtis, 2019)
and mice (Franklin and Ericsson, 2017; Voelkl et al., 2020;
Voelkl and Würbel, 2021; Zhang et al., 2021) (i.e. stress,
microbiota diversity, variation in vaccination dose) may
cause this variability and need to be further evaluated.
Most studies showed Lm-induced immunity against foreignFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 17antigens including tumor associated antigens, HIV-1 gag,
Mycobacterium tuberculosis and Aeromonas hydrophila
(Friedman et al., 2000; Jia et al., 2017; Yin et al., 2017;
Flickinger et al., 2018; Kim et al., 2019; Zeng et al., 2020), and
they focused on the cellular immune response. One of the few
studies that investigated both cellular and humoral immunity
(Mahdy et al., 2019) observed rising antibody titers 14 days after
the first vaccination with 1 x 106 bacteria. In contrast, even
though relatively low in total numbers, we observed significantly
increased antibody titers only after the third dose administration
(6 weeks after the first vaccination) and with tenfold more
bacteria. Differences in genetic content of the engineered
vectors may account for these divergences and suggest the
possibility to tailor immunogenicity of Lm vectors by removal
of virulence genes. In addition, the intrinsic properties of the
antigens under investigation can account for these differences.
The aforementioned study used a Lm DactA/DplcB Lm strain,
while Lm3Dx is deleted in actA, inlA and inlB. PlcB is involved in
listerial vacuolar escape into the cytosol upon infection (Smith
et al., 1995; Quereda et al., 2018). Removal of this gene
potentially increases vacuolar retention and degradation of
Listeria, hence stimulating the delivery of bacterial proteins to
the class II MHC antigen presentation machinery and enforcing
the humoral arm of the immune response (D’Orazio, 2019).
Future investigations will evaluate the persistence of SAG1-
specific antibodies and modulation of the humoral and cellular
immune responses by vector dose and deletion of further
virulence genes.CONCLUSION
We here present an attenuated Listeria vaccine strain, Lm3Dx,
which fulfills multiple safety requirements in vitro and in vivo in
non-pregnant as well as pregnant BALB/c mice. However, its
potential use in lactating animals needs to be further
investigated. Lm3Dx is useful for stable expression of antigens
of interest under the control of the actA promotor and is thus
potentially applicable for the prevention and treatment of cancer
as well as infectious diseases. Lm3Dx_SAG1 stimulates a Th1-
biased immune response against NcSAG1, the major Nc
tachyzoite surface protein, which is a promising neosporosis
vaccine candidate. Considering the important protective role of
Th1 immunity in the context of Nc infection, we suggest that
Lm3Dx_SAG1 could be a potential live vaccine to be used for the
prevention of neosporosis-induced fetal malformations and
abortion. Thus, the safety and efficacy of the Lm3Dx_SAG1
vaccine will be further investigated in a pregnant neosporosis
mouse model. In addition, since N. caninum is a member of the
group of closely related apicomplexans including T. gondii, but
also Besnoitia besnoiti, Sarcocystis, Eimeria and others, all of
which impair human and/or animal health and which are bound
to trigger similar immune responses (Innes and Vermeulen,
2006; Monney et al., 2011; Aguado-Martıńez et al., 2017), our
vaccine vector represents an interesting candidate for a wider
range of applications.August 2021 | Volume 11 | Article 675219
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infection with the parental WT, mutants and Listeria (L.) innocua over time. While the
WT strain replicates efficiently in MDCK cells and clearly spreads between cells, the
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The Lm3Dx mutant and L. innocua are clearly attenuated in invasion efficiency with
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Supplementary File S8 | Immunofluorescence microscopy of DH82 cell infection
with the parental WT, mutants and Listeria (L.) innocua over time. In DH82, the WT,
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Aguado-Martıńez, A., Basto, A. P., Tanaka, S., Ryser, L. T., Nunes, T. P.,
Ortega-Mora, L. M., et al. (2019). Immunization With a Cocktail of
Antigens Fused With OprI Reduces Neospora Caninum Vertical
Transmission and Postnatal Mortality in Mice. Vaccine 37, 473–483.
doi: 10.1016/j.vaccine.2018.11.060
Aguilar-Bultet, L., Nicholson, P., Rychener, L., Dreyer, M., Gözel, B., Origgi, F. C.,
et al. (2018). Genetic Separation of Listeria Monocytogenes Causing Central
Nervous System Infections in Animals. Front. Cell Infect. Microbiol. 8:20.
doi: 10.3389/fcimb.2018.00020
Anvari, D., Saberi, R., Sharif, M., Sarvi, S., Hosseini, S. A., Moosazadeh, M., et al.
(2020). Seroprevalence of Neospora Caninum Infection in Dog Population
Worldwide: A Systematic Review and Meta-Analysis. Acta Parasitol. 65, 273–
290. doi: 10.2478/s11686-019-00163-4
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et al. (2017). Listeria Monocytogenes Switches From Dissemination to
Persistence by Adopting a Vacuolar Lifestyle in Epithelial Cells. PLoS
Pathog. 13, e1006734. doi: 10.1371/journal.ppat.1006734
Lauer, P., Chow, M. Y. N., Loessner, M. J., Portnoy, D. A., and Calendar, R. (2002).
Construction, Characterization, and Use of Two Listeria Monocytogenes Site-
Specific Phage Integration Vectors. J. Bacteriol 184, 4177–4186. doi: 10.1128/
JB.184.15.4177-4186.2002
Lecuit, M., Ohayon, H., Braun, L., Mengaud, J., and Cossart, P. (1997). Internalin
of Listeria Monocytogenes With an Intact Leucine-Rich Repeat Region Is
Sufficient to Promote Internalization. Infect. Immun. 65, 5309–5319.
doi: 10.1128/iai.65.12.5309-5319.1997
Leong, M. L., Hampl, J., Liu, W., Mathur, S., Bahjat, K. S., Luckett, W., et al. (2009).
Impact of Preexisting Vector-Specific Immunity on Vaccine Potency:August 2021 | Volume 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based VaccineCharacterization of Listeria Monocytogenes-Specific Humoral and Cellular
Immunity in Humans and Modeling Studies Using Recombinant Vaccines in
Mice. Infect. Immun. 77, 3958–3968. doi: 10.1128/IAI.01274-08
Liu, D. (2006). Listeria-Based Anti-Infective Vaccine Strategies. Recent Pat.
Antiinfect Drug Discov. 1, 281–290. doi: 10.2174/157489106778777619
Liu, Y., Reichel, M. P., and Lo, W. C. (2020). Combined Control Evaluation for
Neospora Caninum Infection in Dairy: Economic Point of View Coupled With
Population Dynamics. Veterinary Parasitol 277, 108967. doi: 10.1016/j.vetpar.
2019.108967
Maciag, P. C., Radulovic, S., and Rothman, J. (2009). The First Clinical Use of a
Live-Attenuated Listeria Monocytogenes Vaccine: A Phase I Safety Study of
Lm-LLO-E7 in Patients With Advanced Carcinoma of the Cervix. Vaccine 27,
3975–3983. doi: 10.1016/j.vaccine.2009.04.041
Macpherson, A. J., and Uhr, T. (2004). Induction of Protective IgA by Intestinal
Dendritic Cells Carrying Commensal Bacteria. Science 303, 1662–1665.
doi: 10.1126/science.1091334
Mahdy, S. E., Liu, S., Su, L., Zhang, X., Chen, H., Pei, X., et al. (2019). Expression of
the VP1 Protein of FMDV Integrated Chromosomally With Mutant Listeria
Monocytogenes Strain Induced Both Humoral and Cellular Immune
Responses. Appl. Microbiol. Biotechnol. 23, 77–11. doi: 10.1007/s00253-018-
09605-x
Matle, I., Mbatha, K. R., and Madoroba, E. (2020). A Review of Listeria
Monocytogenes From Meat and Meat Products: Epidemiology, Virulence
Factors, Antimicrobial Resistance and Diagnosis. Onderstepoort J. Veterinary
Res. 87, 29. doi: 10.4102/ojvr.v87i1.1869
McAllister, M. M., Dubey, J. P., Lindsay, D. S., Jolley, W. R., Wills, R. A., and
McGuire, A. M. (1998). Rapid Communication: Dogs are Definitive Hosts of
Neospora Caninum. Int. J. Parasitol 28, 1473–1479. doi: 10.1016/S0020-7519
(98)00138-6
Meyer, H., Ehmann, R., and Smith, G. L. (2020). Smallpox in the Post-Eradication
Era. Viruses 2014 6, 2122–2137 12, 138. doi: 10.3390/v12020138
Monney, T., Debache, K., and Hemphill, A. (2011). Vaccines Against a Major
Cause of Abortion in Cattle, Neospora Caninum Infection. Anim. 2011 1, 306–
325. doi: 10.3390/ani1030306. Pages 306-325 1.
Moreno, B., Collantes-Fernández, E., Villa, A., Navarro, A., Regidor-Cerrillo, J.,
and Ortega-Mora, L. M. (2012). Occurrence of Neospora Caninum and
Toxoplasma Gondii Infections in Ovine and Caprine Abortions. Veterinary
Parasitol 187, 312–318. doi: 10.1016/j.vetpar.2011.12.034
Nguyen, D. A., Parlow, A. F., and Neville, M. C. (2001). Hormonal Regulation of
Tight Junction Closure in the Mouse Mammary Epithelium During the
Transition From Pregnancy to Lactation. J. Endocrinol. 170, 347–356.
doi: 10.1677/joe.0.1700347
Nielsen, L., Jensen, T. H., Kristensen, B., Jensen, T. D., Karlskov-Mortensen, P.,
Lund, M., et al. (2012). DNA Vaccines Encoding Proteins From Wild-Type
and Attenuated Canine Distemper Virus Protect Equally Well Against
Wild-Type Virus Challenge. Arch. Virol. 157, 1887–1896. doi: 10.1007/
s00705-012-1375-y
Oevermann, A., Di Palma, S., Doherr, M. G., Abril, C., Zurbriggen, A., and
Vandevelde, M. (2010). Neuropathogenesis of Naturally Occurring
Encephalitis Caused by Listeria Monocytogenes in Ruminants. Brain Pathol.
20, 378–390. doi: 10.1111/j.1750-3639.2009.00292.x
Pamer, E. G. (2004). Immune Responses to Listeria Monocytogenes. Nat. Rev.
Immunol. 4, 812–823. doi: 10.1038/nri1461
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., et al. (2020). Broad and
Strong Memory CD4+ and CD8+ T Cells Induced by SARS-CoV-2 in UK
Convalescent Individuals Following COVID-19. Nat. Immunol. 7, 1–10.
doi: 10.1038/s41590-020-0782-6
Quereda, J. J., Andersson, C., Cossart, P., Johansson, J., and Pizarro-Cerdà, J.
(2018). Role in Virulence of Phospholipases, Listeriolysin O and Listeriolysin S
From Epidemic Listeria Monocytogenes Using the Chicken Embryo Infection
Model. Vet. Res. 49, 1–9. doi: 10.1186/s13567-017-0496-4
Radoshevich, L., and Cossart, P. (2018). Listeria Monocytogenes: Towards a
Complete Picture of its Physiology and Pathogenesis. Nat. Rev. Microbiol.
16, 32–46. doi: 10.1038/nrmicro.2017.126
Reichel, M. P., Alejandra Ayanegui-Alcérreca, M., Gondim, L. F. P., and Ellis, J. T.
(2013). What is the Global Economic Impact of Neospora Caninum in Cattle –
The Billion Dollar Question. Int. J. Parasitol 43, 133–142. doi: 10.1016/
j.ijpara.2012.10.022Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 20Rupp, S., Aguilar-Bultet, L., Jagannathan, V., Guldimann, C., Drögemüller, C.,
Pfarrer, C., et al. (2015). A Naturally Occurring prfA Truncation in a Listeria
Monocytogenes Field Strain Contributes to Reduced Replication and Cell-to-
Cell Spread. Vet. Microbiol. 179, 91–101. doi: 10.1016/j.vetmic.2015.03.002
Sacco, J. J., Evans, M., Harrington, K. J., Man, S., Powell, N., Shaw, R. J., et al.
(2016). Systemic Listeriosis Following Vaccination With the Attenuated
Listeria Monocytogenes Therapeutic Vaccine, ADXS11-001. Hum. Vaccin
Immunother. 12, 1085–1086. doi: 10.1080/21645515.2015.1121338
Safran, H., Leonard, K.-L., Perez, K., Vrees, M., Klipfel, A., Schechter, S.,
et al. (2018). Tolerability of ADXS11-001 Lm-LLO Listeria-Based
Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal
Cancer. Int. J. Radiat. Oncol. Biol. Phys. 100, 1175–1178. doi: 10.1016/
j.ijrobp.2018.01.004
Schares, G., Peters, M., Wurm, R., Bärwald, A., and Conraths, F. J. (1998). The
Efficiency of Vertical Transmission of Neospora Caninum in Dairy Cattle
Analysed by Serological Techniques. Veterinary Parasitol 80, 87–98.
doi: 10.1016/S0304-4017(98)00195-2
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., and Longair, M. (2012). Fiji:
An Open-Source Platform for Biological-Image Analysis. Nat Methods 9, 676–682.
Schlech, W. F. (2019). Epidemiology and Clinical Manifestations of Listeria
Monocytogenes Infection. Microbiol. Spectr. 7 (3), 1–12. doi: 10.1128/
microbiolspec.GPP3-0014-2018
Scortti, M., Han, L., Alvarez, S., Leclercq, A., Moura, A., Lecuit, M., et al. (2018).
Epistatic Control of Intrinsic Resistance by Virulence Genes in Listeria. PLoS
Genet. 14, e1007525. doi: 10.1371/journal.pgen.1007525
Scortti, M., Lacharme-Lora, L., Wagner, M., Chico-Calero, I., Losito, P., and
Vázquez-Boland, J. A. (2006). Coexpression of Virulence and Fosfomycin
Susceptibility in Listeria: Molecular Basis of an Antimicrobial In Vitro-In Vivo
Paradox. Nat. Med. 5 (12), 515–517. doi: 10.1038/nm1396
Sewell, D. A., Pan, Z.-K., and Paterson, Y. (2008). Listeria-Based HPV-16 E7
Vaccines Limit Autochthonous Tumor Growth in a Transgenic Mouse Model
for HPV-16 Transformed Tumors. Vaccine 26, 5315–5320. doi: 10.1016/
j.vaccine.2008.07.036
Sharma, O., Sultan, A. A., Ding, H., and Triggle, C. R. (2020). A Review of the
Progress and Challenges of Developing a Vaccine for COVID-19. Front.
Immunol. 11, 585354. doi: 10.3389/fimmu.2020.585354
Singh, R., and Wallecha, A. (2011). Cancer Immunotherapy Using Recombinant
Listeria Monocytogenes: Transition From Bench to Clinic. Hum. Vaccines 7,
497–505. doi: 10.4161/hv.7.5.15132
Smith, G. A., Marquis, H., Jones, S., Johnston, N. C., Portnoy, D. A., and
Goldfine, H. (1995). The Two Distinct Phospholipases C of Listeria
Monocytogenes Have Overlapping Roles in Escape From a Vacuole and
Cell-to-Cell Spread. Infect. Immun. 63, 4231–4237. doi: 10.1128/iai.63.11.
4231-4237.1995
Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., and Shapiro, M. (2018).
Understanding Modern-Day Vaccines: What You Need to Know. Ann. Med.
50, 110–120. doi: 10.1080/07853890.2017.1407035
Voelkl, B., Altman, N. S., Forsman, A., Forstmeier, W., Gurevitch, J., Jaric, I., et al.
(2020). Reproducibility of Animal Research in Light of Biological Variation.
Nat. Rev. Neurosci. 21, 384–393. doi: 10.1038/s41583-020-0313-3
Voelkl, B., and Würbel, H. (2021). A Reaction Norm Perspective
on Reproducibility. Theor. Biosci. 140, 169–176. doi: 10.1007/s12064-021-
00340-y
Wallecha, A., Petit, R., French, C., and Rothman, J. (2012). Immune Response and
Immunotherapy: Live Attenuated Listeria Monocytogenes (Lm)-LLO
Immunotherapy for the Treatment of Prostate Cancer. Curr. Cancer Ther.
Rev. 8, 254–263. doi: 10.2174/1573394711208040254
Wang, Z., Sun, H., and Yakisich, J. S. (2014). Overcoming the Blood-Brain Barrier
for Chemotherapy: Limitations, Challenges and Rising Problems. Anticancer
Agents Med. Chem. 14, 1085–1093. doi: 10.2174/18715206113139990029
Wendel Naumann, R., Leath, C. A. 3rd. (2020). Advances in Immunotherapy for
Cervical Cancer. Curr. Opin. Oncol. 32 (5), 481–487. doi: 10.1097/
CCO.0000000000000663
Whitten, M. K. (1957). Effect of Exteroceptive Factors on the Oestrous Cycle of
Mice. Nature 180, 1436–1436. doi: 10.1038/1801436a0
Wood, L. M., and Paterson, Y. (2014). Attenuated Listeria Monocytogenes: A
Powerful and Versatile Vector for the Future of Tumor Immunotherapy. Front.
Cell Infect. Microbiol. 4, 51. doi: 10.3389/fcimb.2014.00051August 2021 | Volume 11 | Article 675219
Pownall et al. NcSAG1 Expressing Listeria monocytogenes-Based VaccineYin, Y., Lian, K., Zhao, D., Tao, C., Chen, X., Tan, W., et al. (2017). A Promising
Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers
Protection Against Tuberculosis. Front. Cell Infect. Microbiol. 7, 407.
doi: 10.3389/fcimb.2017.00407
Zebertavage, L., Bambina, S., Shugart, J., Alice, A., Zens, K. D., Lauer, P., et al.
(2019). A Microbial-Based Cancer Vaccine for Induction of EGFRvIII-Specific
CD8+ T Cells and Anti-Tumor Immunity. PLoS One 14, e0209153.
doi: 10.1371/journal.pone.0209153
Zeng, H., Xie, M., Ding, C., Ma, J., Xu, D., Wang, X., et al. (2020). Attenuated
Listeria Monocytogenes as a Vaccine Vector for the Delivery of OMPW, the
Outer Membrane Protein of Aeromonas Hydrophila. Front. Microbiol. 11, 70.
doi: 10.3389/fmicb.2020.00070
Zhang, C., Franklin, C. L., and Ericsson, A. C. (2021). Consideration of Gut
Microbiome in Murine Models of Diseases. Microorganisms 9, 1062.
doi: 10.3390/microorganisms9051062
Zimmermann, P., and Curtis, N. (2019). Factors That Influence the Immune Response
to Vaccination.Clin.Microbiol. Rev. 32 (2), e00084–18. doi: 10.1128/CMR.00084-18Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 21Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Pownall, Imhof, Trigo, Ganal-Vonarburg, Plattet, Monney,
Forterre, Hemphill and Oevermann. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication in
this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.August 2021 | Volume 11 | Article 675219
